Skip to Content

Aventis Pasteur announces shipment of 43 million doses of Fluzone

SWIFTWATER, PA, Nov. 1, 2002--Aventis Pasteur, the nation's largest supplier of influenza vaccine, announced that it has shipped more than 43 million doses of the company's Fluzone Influenza Virus Vaccine this season.

Except for those who had requested deferred shipment, all customers received their orders by October 31.
The company says that these figures represent the largest number of doses it has ever shipped by this date. All customers received partial orders of influenza vaccine in September, in time to vaccinate their high-risk patients, with customers who placed smaller orders receiving their entire order in September. Customers with larger vaccine orders received the balance of their orders in October.

Aventis Pasteur said it is still accepting new orders for shipments of Fluzone vaccine. Health care providers ordering now will receive their vaccine in early November.

"This is good news for healthcare providers who prioritized vaccination of high-risk persons, including the elderly and chronically ill, in accordance with recommendations of the U.S. Centers for Disease Control and Prevention (CDC). Now, they can expand their immunization efforts to include everyone who wants to protect themselves against influenza this season," said Phil Hosbach, Vice President, New Products and Immunization policy for Aventis Pasteur.

Aventis Pasteur made a significant capital investment in 2001 to expand production of its Fluzone influenza vaccine, increasing total capacity by 20 percent. The company is currently evaluating a still greater expansion within the next several years to meet growing demand and to help address the important immunization objectives outlined in the CDC's Healthy People 2010 goals.

The CDC recommends annual influenza vaccination in October for those at high risk for developing serious influenza-related complications. Among the high-risk groups are the elderly and the chronically ill; children with chronic diseases such as asthma; and pregnant women who will be in their second or third trimester of pregnancy during the influenza season. Influenza vaccination is also recommended in October for household contacts of high-risk individuals and health care workers who care for high-risk patients.

Healthy persons aged 50 to 64 and all other healthy individuals who wish to decrease their risk of influenza infection should seek vaccination in November, December and later in the season.

Posted: November 2002